SCHEMBL22923629

SCHEMBL22923629

CC1CC(=O)N(CCCCCN)N=C1c1ccc(NC(=O)N2Cc3ccncc3C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31420843 1.00 NAMPT (0.48) NAMPT
SCHEMBL22923839 1.00 NAMPT (0.48) NAMPT
SCHEMBL20159265 0.99 NAMPT (0.49) NAMPT
SCHEMBL20159177 0.97 NAMPT (0.49) NAMPT
SCHEMBL20159574 0.93 NAMPT (0.51) NAMPT
SCHEMBL20159774 0.91 NAMPT (0.57) NAMPT
SCHEMBL22923577 0.90 NAMPT (0.51) NAMPT
SCHEMBL22923655 0.89 NAMPT (0.49) NAMPT
SCHEMBL22923587 0.89 NAMPT (0.49) NAMPT
SCHEMBL20138896 0.89 NAMPT (0.54) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021013693-A1 ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2021-01-28 WO disclosed